All posts by: Michael Zand

FDA Grants IND of ARTEMIS™ T cell Platform To Enhance CAR-T Cancer Therapies Without Cytokine Storm – MedicalResearch.com (blog)

Antiviral Agent Lowers CMV Risk in Stem Cell Transplant – MedPage Today

MedPage TodayAntiviral Agent Lowers CMV Risk in Stem Cell TransplantMedPage TodayThe antiviral drug letermovir (Prevymis) helped prevent cytomegalovirus in patients with donor bone marrow stem cell transplantation compared with patients who received pl… Continue reading

Routing gene therapy directly into the brain – EurekAlert (press release)

Gene therapy stops bleeding episodes in hemophilia trial – Science Magazine

Science MagazineGene therapy stops bleeding episodes in hemophilia trialScience MagazineResearchers have scored their first clear success in using gene therapy to treat hemophilia, an inherited blood disorder. Ten men received a single intravenous infu… Continue reading

Gene Therapy Shows Promise Against Blood-Clotting Disease – U.S. News & World Report

U.S. News & World ReportGene Therapy Shows Promise Against Blood-Clotting DiseaseU.S. News & World ReportGene Therapy Shows Promise Against Blood-Clotting Disease. A study fuels hope that gene therapy can give long-lasting help and perhaps even cure th… Continue reading

Gene therapy makes a big advance treating hemophilia B blood disorder – Washington Post

Washington PostGene therapy makes a big advance treating hemophilia B blood disorderWashington PostJay Konduros used to rush home several times a year after accidentally cutting or bumping himself. There he would inject himself with refrigerated blood-… Continue reading

Immunotherapy Combinations Poised to Shift Standard of Care in RCC – OncLive

OncLiveImmunotherapy Combinations Poised to Shift Standard of Care in RCCOncLiveOncLive: Please provide an overview of your presentation at this meeting. Hammers: I discussed immunotherapy combinations. It is an exciting time because it is expected tha… Continue reading